RMS555
2 weeks ago
Share Structure updated: Outstanding Shares 627,623,599 09/09/2024
Restricted Shares 15,727,859 09/09/2024
Unrestricted Shares 611,895,740 09/09/2024 https://www.otcmarkets.com/stock/PPCB/security
how many zeros are going to be removed from that after the reverse split??? it may happen any day now since the 20 day waiting period is pretty much done!!
RMS555
4 weeks ago
the reverse split will happen unless its cancelled. It will be 1 for 10,000 or 1 for 100,000 (or somewhere in-between), its in black and white on the DEF 14C: Execute a reverse stock split of the Companyโs issued and outstanding shares of Common Stock at a ratio somewhere between one post-split share per ten thousand pre-split shares (1:10,000) and one post-split share per one hundred thousand pre-split shares (1:100,000) (the โReverse Stock Splitโ). (bold emphasis mine) https://www.otcmarkets.com/filing/html?id=17779588&guid=YeO-kaQlROGaJth
Why is this reverse split the biggest one yet, that is my question. It could be several reasons and PPCB used to have OTCQB status a few years ago. Maybe they are trying to "regain" that status since they are still audited by a PCAOB Auditor (as of last 10-K).
Dynk
4 weeks ago
I gotta ask, if they do a 1 - 10,000 or 1 - 100,000 split with only roughly a little over half a billion shares (557 million and change) that would only leave them with 55 THOUSAND shares at the 1 -10,000 split and only 5 THOUSAND (and change) at the 1 - 100,000 split. WHY?? Personal idea, scare tactic, don't think it will be anywhere near that...if any at all! Cheers everyone!
Marcovich2000
1 month ago
Julian Kenyon is no longer a doctor as his medical license was suspended due to over a decade of constant medical malpractice and fraud. As such, you should not refer to him as doctor. Also, to be clear, his medical fraud has involved more than marijuana. For example, in one case, he used โLIVE BLOOD ANALYSISโ, a bogus diagnostic method that can harm patients through false-negative or false-positive diagnoses. And there have been other instances of fraud and medical malpractice over the past 15 years. But I'm sure none of this will matter to you as you're an old fraud and scammer just like Mr. Kenyon. Due diligence is below:
https://www.mpts-uk.org/-/media/mpts-rod-files/dr-julian-kenyon-16-may-24.pdf
https://www.hampshirechronicle.co.uk/news/11676249.tribunal-rules-twyford-doctor-julian-kenyon-who-exploited-patients-can-keep-job/
https://edzardernst.com/2015/01/why-do-patients-rarely-complain-about-receiving-bogus-treatments/
RMS555
1 month ago
PPCB has progressed since the last 4 rs's in the last 7 years, which will be 5 rs's coming up (your statement is very misleading). PPCB already submitted the paperwork to do another reverse split of 1 for 10,000 or 1 for 100,000.
Did you read the article you linked to? ie. THE FINE PRINT:
The article you linked to specifically states: Therefore, we cannot assure you that the information is accurate or complete. Yet you claim a certain few posters are not to be believed?
The article you linked to specifically states: Green Planet Microcaps was compensated for this article
One more thing, the kick in the crotch (balls) for you: If market cap is so low and the price is right why dont you put all of your money into PPCB and become a gazillionaire if/when PPCB ever does make it to First in Human Trials? lolololol
RMS555
1 month ago
There are other Doctors working with PPCB in different areas. This is from a PR a couple of years ago: Further research is in progress with the Companyโs joint research partners focusing on the effects of PRP on the tumor microenvironment. Results shows that PRP causes reversal of the malignant tumor phenotype (observable characteristics) towards a normal, or benign state, which was, โmost unexpected, very exciting and powerfully conclusive,โ according to Ms. Belen Toledo MSc, from the laboratory of Professor Macarena Perรกn PhD, University of Jaรฉn, Spain. (bold emphasis mine) https://www.otcmarkets.com/stock/PPCB/news/Propanc-Biopharmas-CSO-Reflects-on-Unique-Anti-Cancer-Effects-of-PRP-Discovered-Over-Past-Decade?id=366439
Another in August 2022: today announced that a Joint Research Collaboration Agreement has been established with the Universities of Jaรฉn and Granada, Spain. Since late 2020, Mrs. Belรฉn Toledo Cutillas MSc, has been investigating an important experimental thesis on the effects of proenzyme therapy and the impact on the tumor microenvironment, which is key to the development, invasion, metastatic spread and recurrence of solid tumors. The work is being conducted at the laboratory of Professor Macarena Perรกn PhD, who is the lead researcher on the project and is the second Joint Research Collaboration Agreement currently in progress with the two Spanish Universities. https://www.otcmarkets.com/stock/PPCB/news/Propanc-Biopharma-Establishes-Joint-Research-Collaboration-Agreement-with-the-Universities-of-Jan-and-Granada?id=367214